tirzepatide route of administration 💊 — Mechanism Action & Pharmacokinetics 👨‍⚕️ Mechanism of Action • Tirzepatide is the first dual GIP/GLP-1 receptor agonist. • Activates both: - Glucose-Dependent Insulinotropic Polypeptide (GIP) receptors Tirzepatide - an overview |

These drugs can be really helpful for many people

TRIUMPH-2 featured about 1,150 participants with type-2 diabetes and obesity

In addition to POMC, other markers in the ARC that potentially represent targets for GLP-1RAs are currently being studied

TL;DR: The best supplements for endometriosis support inflammation reduction, estrogen metabolism, gut health, and nervous system regulation

It is a dual agonist, working on both the GLP-1 and GIP receptors, making it a promising candidate in the field of obesity and diabetes research

However, GSIS was decreased following oral but not intraperitoneal glucose administration in DIRKO compared to mice with just one of these receptors knocked out